Rupa Banerjee
Overview
Explore the profile of Rupa Banerjee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
1089
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Banerjee R, Pal P, Hilmi I, Raghunathan N, Rahman M, Limsrivillai J, et al.
Indian J Gastroenterol
. 2024 Jul;
43(6):1156-1167.
PMID: 39023742
Background: Mental health is an overlooked aspect of inflammatory bowel disease (IBD) patient care with limited data from the developing world. The primary caregiver burden is expected to be high,...
2.
Picavet L, van Vroonhoven E, Scholman R, Smits Y, Banerjee R, Besteman S, et al.
Viruses
. 2024 May;
16(5).
PMID: 38793659
Respiratory syncytial virus (RSV) is the most prevalent cause of acute lower respiratory infection in young children. Currently, the first RSV vaccines are approved by the FDA. Recently, N6-methyladenosine (mA)...
3.
Lamb C, Titterton C, Banerjee R, Gomberg A, Rubin D, Hart A
Lancet
. 2024 May;
404(10451):414-417.
PMID: 38768627
No abstract available.
4.
Gahra A, Mathur S, Banerjee R, Patil P, van Hooft J, Kamani L, et al.
Indian J Gastroenterol
. 2024 May;
PMID: 38767807
No abstract available.
5.
Ahuja V, Hilmi I, Ye B, Ling K, Ng S, Leong R, et al.
J Gastroenterol Hepatol
. 2024 May;
39(8):1500-1508.
PMID: 38725188
Inflammatory bowel disease (IBD) is rapidly emerging in the Asia Pacific region. However, there are many challenges in the diagnosis and management of this condition. The Asian Pacific Association of...
6.
Lamb D, Banerjee R, Emanuel T
Can Public Policy
. 2024 Apr;
48(Suppl 1):60-78.
PMID: 38629967
The global coronavirus disease 2019 (COVID-19) pandemic has exposed and arguably intensified many existing inequalities. This analysis explores the relationship between recent immigrant earnings and the pandemic. Specifically, we attempt...
7.
Banerjee R, Sharma V, Patel R, Jena A, Pal P, Raghunathan N, et al.
Indian J Gastroenterol
. 2024 Feb;
43(1):22-35.
PMID: 38347433
Rising number of inflammatory bowel disease (IBD) cases in developing countries necessitate clear guidance for clinicians for the appropriate use of advanced therapies. An expert consensus document was generated to...
8.
Banerjee R, Pal P, Patel R, Godbole S, Komawar A, Mudigonda S, et al.
Lancet Reg Health Southeast Asia
. 2023 Dec;
19:100259.
PMID: 38076713
Background: Traditionally, infectious diarrhoea has been the major cause of lower GI symptoms across the developing world. Increasing urbanization has been implicated for the rising IBD cases despite very limited...
9.
Pal P, Gala J, Rebala P, Banerjee R, Ramchandani M, Nabi Z, et al.
J Gastroenterol Hepatol
. 2023 Oct;
39(2):353-359.
PMID: 37897304
Background And Aim: Resection for Crohn's disease (CD) related strictures is definitive but carries risk of morbidity, recurrence, and short bowel syndrome. On the contrary, the durability of endotherapy (ET)...
10.
Pal P, Banerjee R, Vijayalaxmi P, Reddy D, Tandan M
Indian J Gastroenterol
. 2023 Oct;
43(1):226-236.
PMID: 37851205
Background And Objectives: The prevalence and risk factors of fatigue and sleep disturbances in inflammatory bowel disease (IBD) patients and their impact on the quality of life (QOL) are largely...